Abstract
Background Atherosclerotic cardiovascular disease (CVD) risk differs by ethnicity. In comparison with Europeans (EA) South Asian (SA) people in UK experience higher risk of coronary heart disease and stroke, while African Caribbean people have a lower risk of coronary heart disease but a higher risk of stroke.
Aim To compare carotid atherosclerosis in EA, SA and AC participants in the Southall and Brent Revisited (SABRE) study and establish if any differences were explained by established or novel CVD risk factors.
Methods Cardiovascular risk factors were measured, and carotid ultrasound was performed in 985 individuals (438 EA, 325 SA, 228 AC). Carotid plaques, and intima-media thickness (cIMT) were measured. Associations of carotid atherosclerosis with ethnicity were investigated using regression analyses, with and without adjustment for potential confounders (age, sex) and mediators (education, diabetes, hypertension, total cholesterol, HDL-C, alcohol consumption, current smoking).
Results Prevalence of any plaque was similar in EA and SA, and lower in AC (17%, 17%, and 6% respectively; p < 0.001 by ANOVA). Total plaque area was also similar in EA and SA but reduced in AC, but there were no major differences in the maximum height or length of plaques in people with plaques by ethnic group. These ethnic differences were unaffected by adjustment for potential confounders or mediators. After adjustment for age and sex cIMT was higher in AC but this difference was attenuated by adjustment for CVD risk factors.
Conclusions Prevalence of carotid artery atherosclerotic plaques varies by ethnicity, independent of risk factors. The similarity of plaque burden in SA and EA despite established differences in CVD risk in these ethnic groups casts some doubt on the utility of carotid ultrasound as a means of assessing risk across ethnic groups.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding RA is supported by a PhD scholarship grant from King Abdul-Aziz University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from Ealing, Hounslow and Spelthorne, Parkside, and University College London Research Ethics Committees and all participants provided written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
SABRE data is available to approved researchers upon reasonable request, details can be found at: https://www.sabrestudy.org/home-2/datasharing/.
